A ‘messenger of sex’? Making testosterone matter in motivations for anabolic-androgenic steroid injecting.
Fomiatti R, Latham JR, Fraser S, Moore D, Seear K, Aitken C
Measures of harm reduction service provision for people who inject drugs.
O'Keefe D, Bluthenthal RN, Kral AH, Aitken CK, McCormack A, Dietze PM
Geo-spatial analysis of individual-level needle and syringe coverage in Melbourne, Australia.
O'Keefe D, Wilkinson A, Aitken C, Dietze P
Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis.
Stone J, Fraser H, Lim AG, Walker JG, Ward Z, MacGregor L, Trickey A, Abbott S, Strathdee SA, Abramovitz D, Maher L, Iversen J, Bruneau J, Zang G, Garfein RS, Yen YF, Azim T, Mehta SH, Milloy MJ, Hellard ME, Sacks-Davis R, Dietze PM, Aitken C, Aladashvili M, Tsertsvadze T, Mravčík V, Alary M, Roy E, Smyrnov P, Sazonova Y, Young AM, Havens JR, Hope VD, Desai M, Heinsbroek E, Hutchinson SJ, Palmateer NE, McAuley A, Platt L, Martin NK, Altice FL, Hickman M, Vickerman P
Acceptability of prison-based take-home naloxone programmes among a cohort of incarcerated men with a history of regular injecting drug use.
Curtis M, Dietze P, Aitken C, Kirwan A, Kinner SA, Butler T, Stoové M